BIOETHICS, LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2101 USD | -19.19% |
|
-.--% | -.--% |
Financials (USD)
| Sales 2022 | - | Sales 2023 | - | Capitalization | 239K |
|---|---|---|---|---|---|
| Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 | - |
| Net Debt 2022 | 420K | Net Debt 2023 | 443K | EV / Sales 2023 | - |
| P/E ratio 2022 |
-3.17
x | P/E ratio 2023 |
-2.46
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 11.47% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -19.19% |
3 years
0.21
6.21
5 years
0.2110.60
10 years
0.2127.50
| Managers | Title | Age | Since |
|---|---|---|---|
Mark Scharmann
CEO | Chief Executive Officer | 65 | 15-07-23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mark Scharmann
CEO | Chief Executive Officer | 65 | 15-07-23 |
| Director/Board Member | 65 | 19-12-18 |
Bioethics, Ltd. is a shell company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The Company has not commenced any operations nor generated any revenue.
Sector
Investment Holding Companies
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 239K | |
| +107.89% | 4.54B | |
| +1.84% | 1.01B | |
| +2.00% | 980M | |
| -32.09% | 963M | |
| +41.91% | 872M | |
| +25.02% | 809M | |
| +1.63% | 664M | |
| +0.90% | 612M | |
| -.--% | 600M |
- Stock Market
- Equities
- BOTH Stock
